Thoracic
Prognostic value of preop surgeon intuition vs ACS-NSQIP risk calculator
Editor's Note This study by researchers from Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, finds that preoperative surgeon intuition is an independent predictor of postoperative complications, but it isn’t as strong as the predictive power of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP)…
ASAP model reduces early lung cancer treatment to one day
Editor's Note Sutter Health’s San Francisco-based California Pacific Medical Center (CPMC) has reduced early lung cancer treatment to just 1 day with the help of robotic-assisted bronchoscopy technology, Becker’s Hospital Review February 23 reports. The Assisted Single Anesthetic Procedure (ASAP) allows for multiple procedures to be performed in succession during…
Surgical resident diversity remains largely stagnant
Editor's Note This study led by researchers at Cedars Sinai Medical Center, Los Angeles, finds that underrepresentation of minorities persists across all surgical specialties, while representation of females improves. The cross-sectional study examined race, ethnicity and attrition data of 112,205 surgical residents across 18 years (2001-2018) in 10 surgical specialties.…
FDA: Class I recall of Arrow AutoCAT2, AC3 IABPs
Editor's Note The Food and Drug Administration (FDA), on December 20, identified the recall by Arrow International, LLC, subsidiary of Teleflex, Inc, of its Arrow AutoCAT 2 and AC3 intra-aortic balloon pumps (IABPs) as Class I, the most serious. IABPs are used in patients having cardiac and non-cardiac surgery, and…
Risk factors associated with postop mortality in COVID-19 patients
Editor's Note This study from the Cleveland Clinic finds that COVID-19-positive patients have a higher risk of postoperative mortality, and risk factors should be carefully evaluated before intervention. The analysis included 2,543 patients who had 3,027 surgical procedures. About half of the patients were male with a mean age of…
FDA: Class I recall of LivaNova’s LifeSPARC System
Editor's Note The Food and Drug Administration (FDA) on September 30 identified the recall by LivaNova (TandemLife) of its LifeSPARC System, Model LS-1000, as Class I, the most serious. The recall was initiated because of the risk of unintentional extended pump stop during Controller Critical Failure mode, caused by a…
Free Daily News
- Study: Post-laparotomy incisional negative pressure wound therapy fails to reduce infection risk
- FDA announces multiple Class 1 recalls
- Study: ERAS protocol reduces opioid use after cardiac surgery
- Study: Prehabilitation reduces surgical complications, speeds recovery
- Commentary: Studies show how surgeon decisions follow the money
- Proposed HIPAA updates would improve cybersecurity, increase costs for healthcare providers
- Study: EMR data can enhance hand hygiene compliance, infection prevention
- Study: Machine learning model improves perioperative pain assessment
- Call for improved suicide risk screening in ASCs aims to strengthen safety protocols
- Study: Perioperative pregabalin reduces risk of kidney decline compared to gabapentin